RT

Rahul Thakur

Active Director Director DIN 10909771
DIN 10909771 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value •••• Premium profile

About Rahul Thakur

Data last updated:

Rahul Thakur is a Director at Oystershell Life Sciences Private Limited (since 2025). The company operates in Pharma. Oystershell Life Sciences Private Limited reported revenue of ₹1.11 Cr (FY 2024).

DIN 10909771
Primary Designation Director
Industry Pharma
First Appointment 16 Jan 2025
Oldest Company Age 9 yrs
Largest company Oystershell Life Sciences Private Limited · ₹1.11 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jan 20252017₹1.11 Cr (FY 2024)Active

Board colleagues of Rahul Thakur

Directorship timeline

Open interactive timeline →
Oystershell Life Sciences Private Limited
Premium access

Shareholding and investment profile for Rahul Thakur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Thakur

Rahul Thakur currently holds 1 directorship: Oystershell Life Sciences Private Limited (Director, since 16 Jan 2025, revenue ₹1.11 Cr (FY 2024)).

Rahul Thakur was first appointed on 16 Jan 2025 as Director at Oystershell Life Sciences Private Limited.

The current boards of Rahul Thakur's companies include Anjana Saxena (Oystershell Life Sciences Private Limited), Sohan (Oystershell Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available